Meet us at AHA 2023
Are you coming to AHA 2023 on November 11-13? We'll have a presentation and poster by our Scientific Director and Founder Dr. Peter Würtz. You can also come and discuss with him at our booth. Find more information below.
Our scientist presenting at AHA
Saturday, November 11, Dr. Peter Würtz
Presentation: Metabolomic biomarker profiling improves cardiovascular risk assessment for patients on statins: evidence from 35,000 individuals in the United Kingdom
Identification of individuals who remain at high cardiovascular risk even when using statins can guide second line options for primary prevention. We addressed whether detailed metabolic biomarker profiling has utility in predicting the onset of major adverse cardiovascular events (MACE) and heart failure among individuals already on statin therapy. Detailed metabolic biomarker profiling by a low-cost NMR assay enhanced the prediction of first occurrence of MACE and heart failure beyond established risk factors for individuals already on statin therapy. From a translational perspective, this may complement the residual risk assessment in primary prevention settings and guide allocation of additional therapies to those with most benefit.
Saturday, November 11, 2023
10:10 a.m.-10:15 a.m.
Zone 3‚ Science and Technology Hall‚ Level 2
Monday, November 13, Dr. Peter Würtz
Poster: Metabolic biomarker signatures for incident heart failure hospitalisation compared to different types of cardiovascular events: evidence from NMR metabolomics in 250,000 individuals
Many blood lipids and metabolites are predictors of future cardiovascular events, but their association magnitudes may differ for risk of heart failure hospitalisation and cardiovascular outcomes. We measured detailed plasma lipids and metabolites by NMR metabolomics in around 250,000 individuals from the UK Biobank. We assessed shared and discordant biomarkers for heart failure hospitalisation in relation to myocardial infarction, ischemic stroke, peripheral artery disease, cardiac arrest and cardiovascular death and show that heart failure and different cardiovascular endpoints have partly different metabolic biomarkers signatures.
Monday, November 13, 2023
10:30 a.m.-11:45 a.m.
Board no. 1048
Meet the experts at our booth 1325
Meet Dr. Peter Würtz at our booth 1325 during AHA:
On Saturday between 3:00 p.m. and 4:00 p.m.
On Sunday between 11:30 a.m. and 12:30 p.m.
You can also meet our team at booth 1325 or book a meeting with us by emailing research@nightingalehealth.com.
Subscribe to our newsletter
Nightingale Health Research News is a newsletter for scientists sharing insights on the latest publications in the field of metabolic profiling, stories from researchers we work with, the benefits of using Nightingale Health's technology to fuel research, and to hear about our new webinars.